|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.25 USD | +0.26% |
|
-6.69% | -15.53% |
| 12-03 | BIONTECH : Gets a Buy rating from Jefferies | ZD |
| 12-03 | BioNTech Says Minimum Condition Met in CureVac Exchange Offer | MT |
| Capitalization | 19.89B 23.14B 18.64B 17.37B 32.08B 2,083B 34.9B 218B 84.17B 984B 86.86B 85.01B 3,597B | P/E ratio 2025 * |
-25.6x | P/E ratio 2026 * | -33.6x |
|---|---|---|---|---|---|
| Enterprise value | 9.16B 10.66B 8.58B 8B 14.77B 959B 16.07B 100B 38.75B 453B 39.99B 39.14B 1,656B | EV / Sales 2025 * |
3.4x | EV / Sales 2026 * | 3.57x |
| Free-Float |
86.48% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioNTech SE
More press releases
More news
| 1 day | +0.26% | ||
| 1 week | -6.69% | ||
| Current month | -6.69% | ||
| 1 month | -6.94% | ||
| 3 months | -14.41% | ||
| 6 months | -12.62% | ||
| Current year | -15.53% |
| 1 week | 95.21 |  | 101.84 |
| 1 month | 94 | | 113.39 |
| Current year | 81.2 | | 129.27 |
| 1 year | 81.2 | | 129.27 |
| 3 years | 76.53 | | 188.98 |
| 5 years | 76.53 | | 464 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/12/2017 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 01/06/2008 |
Sierk Poetting
DFI | Director of Finance/CFO | 52 | 31/08/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 01/06/2008 |
| Director/Board Member | 68 | 01/06/2008 | |
| Director/Board Member | 64 | 31/12/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.92% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | -6.69% | -19.01% | -42.27% | 23.14B | |
| -2.68% | -1.46% | +30.24% | +105.16% | 54.89B | |
| -0.51% | -1.81% | +170.81% | +925.64% | 43.51B | |
| +0.90% | -0.87% | +75.84% | +15.31% | 38.12B | |
| -1.45% | -0.34% | +30.97% | -37.78% | 19.5B | |
| -0.97% | +4.69% | +98.42% | -40.74% | 17.25B | |
| +0.57% | +0.98% | +89.61% | +302.27% | 14.68B | |
| -2.66% | +2.35% | +4.51% | +2,232.48% | 14.12B | |
| +2.45% | +0.79% | +147.98% | - | 13.78B | |
| -1.52% | -3.30% | +84.41% | +692.23% | 13.11B | |
| Average | -0.56% | -0.69% | +71.38% | +461.37% | 25.21B | |
| Weighted average by Cap. | -0.75% | -1.20% | +72.86% | +374.47% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.69B 3.13B 2.52B 2.35B 4.35B 282B 4.73B 29.53B 11.4B 133B 11.77B 11.51B 487B | 2.61B 3.03B 2.44B 2.28B 4.21B 273B 4.57B 28.57B 11.03B 129B 11.39B 11.14B 471B |
| Net income | -823M -957M -771M -719M -1.33B -86.17B -1.44B -9.02B -3.48B -40.7B -3.59B -3.52B -149B | -527M -613M -493M -460M -849M -55.13B -924M -5.77B -2.23B -26.04B -2.3B -2.25B -95.21B |
| Net Debt | -10.73B -12.49B -10.06B -9.37B -17.31B -1,124B -18.83B -118B -45.42B -531B -46.87B -45.87B -1,941B | -10.58B -12.3B -9.91B -9.23B -17.06B -1,107B -18.55B -116B -44.74B -523B -46.17B -45.19B -1,912B |
More financial data
* Estimated data
Employees
6,772
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 96.25 $ | +0.26% | 1,270,288 |
| 04/12/25 | 96.00 $ | -0.75% | 1,609,431 |
| 03/12/25 | 96.73 $ | +0.65% | 3,483,598 |
| 02/12/25 | 96.11 $ | -1.31% | 2,097,817 |
| 01/12/25 | 97.39 $ | -5.58% | 1,760,864 |
Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
82.74EUR
Average target price
117.99EUR
Spread / Average Target
+42.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition